Medicare drug price negotiations need something new

HHS Selects 15 New Drugs for Medicare Part D Price Negotiations
As part of the Inflation Reduction Act, price negotiations with manufacturers will begin this year, with reduced prices expected to take effect in 2027.
Medicare to Negotiate Prices for 15 More Drugs, Including Ozempic
Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people w
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.
Medicare targets 15 more drugs for price negotiations — including Ozempic
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare.
Government picks 15 more prescription drugs for Medicare price negotiation
The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), has selected 15 additional drugs for pr
Fact Check: Did Trump Raise Prescription Drug Prices?
Trump reversed former President Joe Biden's order on "Lowering Prescription Drug Costs for Americans" on Monday.
Trump rolls back effort to lower Medicare, Medicaid drug costs
Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.
Yes, Trump rescinded Biden's order to lower prescription drug costs for people on Medicare and Medicaid
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started, so current drug prices are unaffected.
Medicare, Medicaid Out-of-Pocket Drug Costs Expected to Increase
The directive for the Department of Health and Human Services to develop and test new models aimed at lowering drug costs through the
6 Possible Changes Coming to Prescription Drug Costs Under Trump’s Presidency
The majority of Americans think prescription drug costs are unreasonable and believe a major contributor to the high cost is profits made by pharmaceutical companies, a survey by KFF found.
Departed Biden Medicare Chief Lauds Landmark Drug Negotiations
Meena Seshamani’s Medicare swan song ended on a note of bravura: the announcement that 15 costly drugs, including Novo ...
STAT8d
Former Trump White House, HHS aide Abe Sutton likely to lead Medicare, Medicaid innovation center
Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...
MM&M4d
Ozempic and Wegovy make the list of the next 15 drugs in Medicare negotiations: HHS
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...
Becker's Hospital Review6d
Trump's plans for HHS: 13 knowns
1. Mr. Trump announced in November 2024 that Robert F. Kennedy Jr., son of former Attorney General Robert F. Kennedy and nephew to President John F. Kennedy, is his pick for HHS Secretary. Mr. Kennedy ...
JD Supra4d
EnforceMintz —Could the Supreme Court’s Decision in Jarkesy Mean the End to HHS Civil Monetary Penalty Authorities as We Know Them?
Last June, the Supreme Court issued its decision in Securities and Exchange Commission v. Jarkesy, which holds that the ...
Fierce Healthcare4d
Former HHS official and Warp Speed leader Paul Mango dies
Paul Mango, a senior health official during President-elect Donald Trump's first term who was a member of Trump's current ...
HHS Secretary Becerra urges Trump administration to 'continue to grow' the ACA
As of Monday, FDA commissioner Robert Califf, Department of Health and Human Services (HHS) Secretary Xavier Becerra, ...
ENDPOINTS NEWS5d
HHS blasts Boehringer's drug price case, re­veals new de­tails on Jar­diance talks
HHS told the Second Circuit that Boehringer Ingelheim’s voluntary participation in Medicare negotiations “undermines” its ...